You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for GNP IBUPROFEN PM CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP IBUPROFEN PM CAPLET

Average Pharmacy Cost for GNP IBUPROFEN PM CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12790 EACH 2025-03-19
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12495 EACH 2025-02-19
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12271 EACH 2025-01-22
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12258 EACH 2024-12-18
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12201 EACH 2024-11-20
GNP IBUPROFEN PM CAPLET 46122-0708-60 0.12605 EACH 2024-10-23
GNP IBUPROFEN PM CAPLET 46122-0708-41 0.12605 EACH 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Global Ibuprofen Market Analysis and Price Projections for Ibuprofen PM

Introduction to Ibuprofen PM

Ibuprofen PM, often formulated as a combination of ibuprofen and diphenhydramine, is a widely used medication for pain relief and insomnia. This article delves into the global ibuprofen market, focusing on the market analysis, growth drivers, regional performance, and price projections for Ibuprofen PM.

Global Ibuprofen Market Size and Growth

The global ibuprofen market is projected to experience steady growth over the coming years. Here are some key statistics:

  • The global ibuprofen market was valued at USD 1.43 billion in 2023 and is expected to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period (2024-2032)[1].
  • Another report estimates the market size to be around USD 121.6 million in 2024, with a projected growth to USD 215.24 million by 2031 at a CAGR of 8.50%[4].

Drivers of Market Growth

Several factors are driving the growth of the global ibuprofen market:

  • Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as rheumatoid arthritis, osteoarthritis, headaches, and cardiovascular diseases is a significant driver. Growing public awareness about these conditions further fuels the demand for ibuprofen[1][3][4].
  • Urbanization and Healthcare Spending: Rising urbanization and increased healthcare spending, particularly in regions like Asia-Pacific, contribute to the market's growth. The healthcare benefit cost trends in Asia-Pacific have been rising, supporting the demand for ibuprofen[1].
  • Self-Medication Trend: The growing adoption of self-medication for minor ailments is boosting the ibuprofen market. Consumers increasingly prefer over-the-counter pain relief solutions, reducing the need for medical consultations[4].

Regional Market Performance

The global ibuprofen market is segmented into several regions, each with its own growth dynamics:

  • Asia-Pacific: This region is the largest market shareholder and is expected to expand substantially. Countries like China and India, with their cost-efficient manufacturing and rising healthcare expenditures, drive this growth. India's aging population, projected to increase from 137.9 million in 2021 to 193.8 million by 2031, also contributes to the demand for ibuprofen[1].
  • North America: This region holds a significant market share and is expected to grow at a CAGR of 6.7% from 2024 to 2031. The United States and Canada are key markets within North America[4].
  • Europe: Europe accounts for over 30% of the global revenue and is expected to grow at a CAGR of 7.0% from 2024 to 2031[4].
  • Latin America and Middle East & Africa: These regions also show growth potential, albeit at a slower pace compared to the other regions[4].

Price Projections for Ibuprofen PM

The pricing of Ibuprofen PM can vary based on several factors, including the pharmacy, location, and availability of discounts.

  • Current Pricing: The cost for Ibuprofen PM (38 mg-200 mg) oral tablets can range from $12.25 for a supply of 20 tablets, depending on the pharmacy and the use of discount cards[2].
  • Discounts and Patient Assistance: Various discount programs, such as the Drugs.com Discount Card, can save consumers up to 80% on the cost of ibuprofen and other medications. However, no specific patient assistance programs were found for Ibuprofen PM[2].

Impact of Regulatory Changes

Regulatory changes can influence the pricing and availability of ibuprofen. For instance:

  • Price Increase Notification: As of April 1, 2024, the National Pharmaceutical Pricing Authority (NPPA) announced an increase in the Maximum Retail Price (MRP) of scheduled formulations, including ibuprofen, by 0.00551 percent[1].

Market Segmentation and Product Preferences

The ibuprofen market is segmented based on dosage form, type, end-user, and application.

  • Dosage Forms: Tablets are the dominating category due to their ease of administration, accurate dosing, and cost-effectiveness. They are favored in both prescription and over-the-counter markets[4].

Strategic Initiatives by Industry Players

Key industry players are engaging in various strategic initiatives to drive market growth:

  • Investments and Expansions: Companies like IOL Chemicals & Pharmaceuticals are investing in capital expenditures to establish new plants and diversify their product portfolios, which includes ibuprofen. Such initiatives are expected to bolster the market share in regions like India[1].

Key Takeaways

  • The global ibuprofen market is expected to grow steadily, driven by the rising prevalence of chronic diseases, increasing healthcare spending, and the trend towards self-medication.
  • Asia-Pacific is the largest market shareholder, with significant growth expected due to cost-efficient manufacturing and an aging population.
  • North America and Europe also hold substantial market shares and are expected to grow at notable CAGRs.
  • The pricing of Ibuprofen PM can be influenced by discounts and regulatory changes.
  • Tablets remain the preferred dosage form due to their ease of use and cost-effectiveness.

FAQs

Q: What is the projected global ibuprofen market size by 2032? A: The global ibuprofen market is expected to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period (2024-2032)[1].

Q: Which region is the largest market shareholder for ibuprofen? A: Asia-Pacific is the largest market shareholder for ibuprofen, driven by cost-efficient manufacturing and rising healthcare expenditures[1].

Q: What are the key drivers of the ibuprofen market growth? A: The key drivers include the rising prevalence of chronic diseases, increasing healthcare spending, and the trend towards self-medication[1][3][4].

Q: How much does Ibuprofen PM typically cost? A: The cost for Ibuprofen PM (38 mg-200 mg) oral tablets can range from $12.25 for a supply of 20 tablets, depending on the pharmacy and the use of discount cards[2].

Q: Are there any patient assistance programs available for Ibuprofen PM? A: No specific patient assistance programs were found for Ibuprofen PM, although general discount programs like the Drugs.com Discount Card can offer significant savings[2].

Sources

  1. Straits Research: Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report ...
  2. Drugs.com: Ibuprofen PM Prices, Coupons, Copay Cards & Patient Assistance
  3. Verified Market Research: Ibuprofen Market Size, Share, Scope, Trends, Growth & Forecast
  4. Cognitive Market Research: Global ibuprofen market size is USD 121.6 million in 2024.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.